Elutia Inc
NASDAQ:ELUT

Watchlist Manager
Elutia Inc Logo
Elutia Inc
NASDAQ:ELUT
Watchlist
Price: 1.72 USD 1.18% Market Closed
Market Cap: 70.3m USD

Wall Street
Price Targets

ELUT Price Targets Summary
Elutia Inc

Wall Street analysts forecast ELUT stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for ELUT is 9.18 USD with a low forecast of 8.08 USD and a high forecast of 10.5 USD.

Lowest
Price Target
8.08 USD
370% Upside
Average
Price Target
9.18 USD
434% Upside
Highest
Price Target
10.5 USD
510% Upside
Elutia Inc Competitors:
Price Targets
4597
Solasia Pharma KK
84% Upside
300122
Chongqing Zhifei Biological Products Co Ltd
56% Upside
600161
Beijing Tiantan Biological Products Corp Ltd
67% Upside
EXAS
Exact Sciences Corp
24% Upside
OPK
OPKO Health Inc
223% Upside
ALKS
Alkermes Plc
38% Upside
1530
3SBio Inc
40% Downside
301047
Sino Biological Inc
27% Upside

Revenue
Forecast

Revenue Estimate
Elutia Inc

For the last 5 years the compound annual growth rate for Elutia Inc's revenue is -11%. The projected CAGR for the next 2 years is 50%.

-11%
Past Growth
50%
Estimated Growth
Estimates Accuracy
-2%
Average Miss

Operating Income
Forecast

Operating Income Estimate
Elutia Inc

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-14%
Average Miss

Net Income
Forecast

Net Income Estimate
Elutia Inc

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-71%
Average Miss
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is ELUT's stock price target?
Price Target
9.18 USD

According to Wall Street analysts, the average 1-year price target for ELUT is 9.18 USD with a low forecast of 8.08 USD and a high forecast of 10.5 USD.

What is Elutia Inc's Revenue forecast?
Projected CAGR
50%

For the last 5 years the compound annual growth rate for Elutia Inc's revenue is -11%. The projected CAGR for the next 2 years is 50%.

Back to Top